Rutgers University-New Brunswick · NeuroscienceGlycoNeuro Lab
Michal Schnaider Beeri · New Brunswick, New Jersey
Research Focus
Dr. Michal Schnaider Beeri's lab at Rutgers focuses on understanding the complex roles of glycoproteins in Alzheimer's disease and related disorders. By studying the modifications on brain proteins, their work aims to identify new biomarkers and potential treatments that can help preserve cognitive and motor function in aging individuals. The lab utilizes advanced techniques and large datasets to explore how an active lifestyle may influence brain health through these glycoproteins.
Alzheimer's diseaseglycoproteomecognitive declinedementiapost-translational modificationsdrug discoverygenetic architectureactive lifestylebiomarkers
Research Aims
5AIM 01Identify novel glycopeptiforms linked to Alzheimer's disease pathologies.
AIM 02Examine the relationship between active lifestyles and brain health through glycoproteins.
AIM 03Characterize the genetic architecture of brain glycoproteins related to Alzheimer's risk.
AIM 04Replicate findings in independent cohorts to validate results.
AIM 05Test if resilience glycopeptiforms mediate benefits of active lifestyles.
Skills the Lab Values
bioinformaticsproteomic analysiswhole genome sequencingstatistical modelingdata integrationclinical measures assessmentcohort study designglycopeptide mappinggenomic data analysis
Output against the department
Publications403top 15% of dept.102nd of 671
this lab
most publishedleast published
Citations8.9ktop 44% of dept.295th of 671
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.